Detalles de la búsqueda
1.
Incidence of primary hepatitis C infection among people who inject drugs during 2012-2020 in Athens, Greece.
J Viral Hepat
; 2024 May 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38742938
2.
Successful therapy with tenofovir disoproxil fumarate (TDF) in patients with chronic hepatitis B (CHB) does not guarantee amelioration of liver damage assessing by transient elastography. A retrospective - prospective multicenter study.
BMC Gastroenterol
; 24(1): 133, 2024 Apr 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-38609880
3.
A Current Synopsis of the Emerging Role of Extracellular Vesicles and Micro-RNAs in Pancreatic Cancer: A Forward-Looking Plan for Diagnosis and Treatment.
Int J Mol Sci
; 25(6)2024 Mar 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-38542378
4.
HERACLIS-HDV cohort for the factors of underdiagnosis and prevalence of hepatitis D virus infection in HBsAg-positive patients.
Liver Int
; 43(9): 1879-1889, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37288712
5.
The Arising Role of Extracellular Vesicles in Cholangiocarcinoma: A Rundown of the Current Knowledge Regarding Diagnostic and Therapeutic Approaches.
Int J Mol Sci
; 24(21)2023 Oct 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-37958547
6.
An artificial intelligence model to predict hepatocellular carcinoma risk in Korean and Caucasian patients with chronic hepatitis B.
J Hepatol
; 76(2): 311-318, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34606915
7.
Impact of HBeAg on Hepatocellular Carcinoma Risk During Oral Antiviral Treatment in Patients With Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 20(6): 1343-1353.e16, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34500103
8.
Significance of serum HBV RNA in non-cirrhotic HBeAg-negative chronic hepatitis B patients who discontinue effective antiviral therapy.
J Viral Hepat
; 29(11): 948-957, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35789515
9.
Hepatocellular carcinoma after treatment cessation in non-cirrhotic HBeAg-negative chronic hepatitis B: A multicentre cohort study.
Liver Int
; 42(3): 541-550, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34890120
10.
Noninvasive, Blood-Based Biomarkers as Screening Tools for Hepatic Fibrosis in People With Type 2 Diabetes.
Clin Diabetes
; 40(3): 327-338, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35983425
11.
The Emerging Role of Extracellular Vesicles and Autophagy Machinery in NASH-Future Horizons in NASH Management.
Int J Mol Sci
; 23(20)2022 Oct 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-36293042
12.
Long-term clinical outcome of HBeAg-negative chronic hepatitis B patients who discontinued nucleos(t)ide analogues.
Liver Int
; 41(1): 48-57, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33373114
13.
The burden and management of anemia in Greek patients with inflammatory bowel disease: a retrospective, multicenter, observational study.
BMC Gastroenterol
; 21(1): 269, 2021 Jun 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34187376
14.
Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B.
J Hepatol
; 72(6): 1088-1096, 2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31981727
15.
Similar risk of hepatocellular carcinoma during long-term entecavir or tenofovir therapy in Caucasian patients with chronic hepatitis B.
J Hepatol
; 73(5): 1037-1045, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-32553667
16.
Predictors of hepatitis B surface antigen loss, relapse and retreatment after discontinuation of effective oral antiviral therapy in noncirrhotic HBeAg-negative chronic hepatitis B.
J Viral Hepat
; 27(2): 118-126, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31562748
17.
Randomized clinical trials towards a single-visit cure for chronic hepatitis C: Oral GSK2878175 and injectable RG-101 in chronic hepatitis C patients and long-acting injectable GSK2878175 in healthy participants.
J Viral Hepat
; 27(7): 699-708, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32096313
18.
Immunological biomarkers as indicators for outcome after discontinuation of nucleos(t)ide analogue therapy in patients with HBeAg-negative chronic hepatitis B.
J Viral Hepat
; 26(6): 697-709, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30702196
19.
Significance of definitions of relapse after discontinuation of oral antivirals in HBeAg-negative chronic hepatitis B.
Hepatology
; 68(2): 415-424, 2018 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28859219
20.
Alteration of small intestinal occludin and ZO-1 expession in liver cirrhosis.
Pathol Int
; 74(3): 154-156, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38251871